Results 161 to 170 of about 655,147 (306)
The incidence of serious complications after selective laser trabeculoplasty
Acta Ophthalmologica, Volume 104, Issue 1, Page 106-113, February 2026.Abstract Purpose To evaluate the incidence of serious complications after selective laser trabeculoplasty (SLT). Methods All patients who underwent SLT at the Department of Ophthalmology, Helsinki University Hospital, were eligible for the study from 1 January 2012 to 31 December 2018.
Eeva S. Ojanen +2 more
wiley +1 more source
Drug Interaction Study Of Apixaban With Cyclosporine Or Tacrolimus: Results From A Phase 1, Randomized, Open-Label, Crossover Study In Healthy Volunteers [PDF]
, 2018 BACKGROUND Solid organ transplant recipients commonly require anticoagulation. Apixaban (APX) is principally metabolized by CYP3A4, undergoes direct intestinal excretion, and is a substrate to P-glycoprotein (P-gp) and Breast Cancer Resistance Protein ...
Bashir, MD, Babar +5 more
core +1 more source
The Effect of Contrast Agents on the Anticoagulant Properties of Oral Factor Xa Inhibitors [PDF]
, 2021 Burcu Tuncay +5 more
openalex +1 more source
The FASEB Journal, Volume 40, Issue 1, 15 January 2026.Treatment using either the thiol isomerase inhibitor isoquercetin or zafirlukast lowers tissue factor levels, decreases VEGF, inhibits PD‐L1, and TMEM176B in a xenograft model of ovarian cancer. A combination of the two agents, at threefold lower concentrations than either drug, significantly enhanced the inhibition further, suggesting a dual action of
Justine A. Keovilay +4 more
wiley +1 more source
What will be the role of andexanet alfa (Ondexxya®), the first specific antidote for factor Xa inhibitors? [PDF]
, 2023 Serge Motte
openalex +1 more source